The best treatment for the management of hemodynamically significant patent ductus arteriosus in preterm neonates : a network meta-analysis and risk-benefit analysis
Various pharmacological treatments are available for preterm infants with patent ductus arteriosus (PDA) but their risks and benefits are controversial. This study aimes to identify the best treatment of PDA using network meta-analysis (NMA) and risk-benefit assessment (RBA). Relevant randomized controlled trials (RCTs...
S. Eursiriwan
· 0 citations